RxDoctor Payments Data

Caroline Tuchowski, PA

Physician Assistant · Marquette, MINPI 1699287953

Payments from drug & device makers

$3,927in general payments, 2019–2025

Across 56 payments — averaging $70.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Eli Lilly$2K
  • Amgen$693
  • UCB, Inc.$242
  • AstraZeneca$194
  • Janssen Scientific Affairs, LLC$104
  • Sanofi$104
  • plus $190 from 7 others

What the payments were for

  • Speaking & faculty fees$2,40061%
  • Food & beverage$1,52739%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,927 in reported general payments places this provider in the 90th percentile of 5,453 physician assistant providers in Michigan.

See all physician assistant providers in Michigan

Medicare billing

Part B allowed, 2024
$101,884
Medicare patients
81
Services billed
6,031

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Enbrel MiniEtanercept13$110,385
Humira(Cf) PenAdalimumab14$93,760
Humira(Cf)Adalimumab13$90,734
OrenciaAbatacept14$82,126
Enbrel SureclickEtanercept11$81,482
ForteoTeriparatide11$47,189
Hydroxychloroquine Sulfate306$13,076
MethotrexateMethotrexate Sodium258$5,541
Leflunomide90$5,430
Celecoxib100$3,361
Pilocarpine Hcl11$1,672
Sulfasalazine DrSulfasalazine44$1,561
Sulfasalazine60$1,407
Mycophenolate Mofetil18$1,122
Colchicine29$1,081

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieHumira(Cf)$94$90,73413 claims
Lilly USA, LLCForteo$14$47,18911 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 5,453 physician assistant providers in Michigan.

Other physician assistant in Marquette

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →